BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ByAinvest
Wednesday, Jan 28, 2026 12:16 am ET1min read
BBIO--
BridgeBio Pharma announced inducement grants under Nasdaq Listing Rule 5635(c)(4), approving equity grants to 11 new employees for a total of 31,428 shares of common stock. One-fourth of the shares will vest on February 16, 2027, with the remaining shares vesting quarterly thereafter, subject to continued employment with the Company. The grants were made under the Amended and Restated 2019 Inducement Equity Plan.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet